Check Your Symptoms
Find A Doctor
Health A-Z
Drugs & Supplements
Living & Healthy
Family & Pregnancy
News & Experts
Subscriptions

Lung Cancer

Understanding EGFR Mutations in Non-Small-Cell Lung Cancer

What is EGFR-Positive Lung Cancer?

Testing for Your Condition

Comprehensive biomarker testing can identify EGFR or other mutations in your lung cancer. Learn the benefits of testing and how it can help shape treatment.

Explore More

How EGFR-Positive Lung Cancer Is Treated

Depending on the stage and specific mutation of this lung cancer, there are several treatment options and “lots of hope,” says oncologist Susan Scott, MD.

Therapies and Treatments to Consider

Some non-small-cell lung cancers (NSCLC) have changes in a gene called EGFR. If your NSCLC has these mutations, your doctor likely will recommend treatment with targeted therapies that block EGFR. Learn what you should know about your treatment options and outlook.

Which Demographics Are More at Risk?

Who’s most at risk for getting EGFR-positive lung cancer? Learn which factors increase your chances.

Exploring Clinical Trials

You’ll have more treatment options for EGFR-positive non-small-cell lung cancer (NSCLC) now than ever before. But doctors are still testing new treatments and combinations in clinical trials. Find out if a clinical trial may be an option for you.

See More on Lung Cancer From WebMD

About WebMD
Advertise With Us

Terms of Use
Privacy Policy

Cookie Policy
Editorial Policy

Contact Us

AdChoice

©2005-2023 WebMD LLC. All rights reserved. WebMD does not provide medical advice, diagnosis or treatment. See additional information.